Structure Therapeutics In... (GPCR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
27.00
1.62 (6.38%)
At close: Jan 15, 2025, 10:58 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 949.17K | 623.26K | 266.35K | 20.03K |
Gross Profit | -949.17K | -623.26K | -266.35K | -20.03K |
Operating Income | -102.78M | -52.56M | -37.70K | -15.91K |
Interest Income | 13.38M | 1.26M | 122.00 | 168.29K |
Pretax Income | -89.38M | -51.30M | -37.82K | -15.74K |
Net Income | -89.62M | -51.32M | -38.05K | -15.88K |
Selling & General & Admin | 32.67M | 16.37M | 8.59K | 3.54K |
Research & Development | 70.10M | 36.19M | 29.11K | 12.36K |
Other Expenses | 0.00 | n/a | n/a | n/a |
Operating Expenses | 102.78M | 52.56M | 37.70K | 15.91K |
Interest Expense | 13.39M | n/a | 122.16K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 102.78M | 52.56M | 37.70K | 15.91K |
Income Tax | 236.00K | 17.00K | 231.00 | 138.00 |
Shares Outstanding (Basic) | 36.73M | 36.59M | 36.59M | 36.59M |
Shares Outstanding (Diluted) | 36.73M | 36.59M | 36.59M | 36.59M |
EPS (Basic) | -2.44 | -1.4 | -0.00 | -0.00 |
EPS (Diluted) | -2.44 | -1.4 | -0.00 | -0.00 |
EBITDA | -102.46M | -52.28M | -37.62M | -15.75M |
Depreciation & Amortization | 316.00K | 623.26K | 266.35K | 20.03K |